• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Aptar Appoints Candace Matthews to the Board of Directors

    5/24/21 4:32:00 PM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that Candace Matthews has joined its Board of Directors.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210524005808/en/

    Candace Matthews Joins Aptar Board of Directors

    Candace Matthews Joins Aptar Board of Directors

    Candace is a highly accomplished business leader with over 30 years of experience developing and marketing products for the healthcare, cosmetics, food and beverage industries. Candace currently serves as the Chief Reputation Officer for Amway, overseeing the company's global reputation strategy and brand, along with its corporate social responsibility and enterprise sustainability program. Prior to this role, Candace was Amway's Regional President of the Americas and before that, Chief Marketing Officer. With decades of international leadership experience, Candace has spent a significant amount of time in Asia, particularly in China, deeply immersing herself in the region and its cultures.

    Prior to her leadership roles at Amway, Candace served as President of the SoftSheen-Carson, Consumer Products Division of L'Oréal USA, held leadership roles at The Coca-Cola Company and CIBA Vision Corporation, and worked for several other notable companies such as Bausch + Lomb, Procter & Gamble and General Mills.

    "We are delighted to welcome Candace Matthews to our Board of Directors. Our directors provide valuable guidance and keen oversight based on their first-hand operating experience in the end-markets and geographic regions in which we operate as well as functional expertise and multicultural insights. Candace is a valuable addition to Aptar's Board with deep, contemporary knowledge of our markets and a formidable business network," said Stephan B. Tanda, Aptar President and CEO.

    Commenting on Aptar's Board membership, George Fotiades, Chairman of the Board, stated, "We have an exceptionally talented and diverse Board of Directors at Aptar and we continue to further develop the Board. With 45% of our Board now consisting of women, all Board committees chaired by women, and 27% of our Board comprised of persons of color, we are proud to be among the companies leading the way towards greater diversity and gender balance on corporate boards."

    "Aptar has a legacy of innovation and leadership in key consumer and drug delivery markets and is a trusted partner to many of the world's leading brands," said Candace Matthews, Aptar Board of Directors. "I am excited to join Aptar's well-respected and strategic-minded Board of Directors as the company continues its transformative impact on the future of consumer and healthcare product development around the world."

    Candace holds an MBA from Stanford Graduate School of Business and a Bachelor's of Science in Metallurgical Engineering and Administrative and Management Science from Carnegie Mellon University. She currently serves on the Board of Directors for Herman Miller and BIC and was previously a director for Popeyes Louisiana Kitchen.

    About Aptar

    Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar's innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world's leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005808/en/

    Get the next $ATR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    1/3/2024$125.00 → $150.00Neutral → Outperform
    Robert W. Baird
    1/20/2022$150.00 → $126.00Equal-Weight
    Morgan Stanley
    12/22/2021$162.00 → $156.00Overweight
    Wells Fargo
    12/20/2021$148.00 → $145.00Buy
    Deutsche Bank
    More analyst ratings

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Aptar Reports First Quarter 2025 Results

      AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following first quarter results for the period ended March 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501642213/en/Aptar Reports First Quarter 2025 Results First Quarter 2025 Highlights (compared to the prior year quarter) Reported sales of $887 million, a 3% decrease, and reported net income of $79 million, a 5% decrease Core sales were flat and adjusted EBITDA increased 3% from the prior year to $183 mill

      5/1/25 5:03:00 PM ET
      $ATR
      Plastic Products
      Industrials
    • Aptar Declares Quarterly Dividend

      AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to stockholders of record as of May 1, 2025. As previously announced, Aptar will hold a conference call on Friday, May 2, 2025 at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the website. About Aptar

      4/17/25 5:00:00 PM ET
      $ATR
      Plastic Products
      Industrials
    • Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

      SmartTrack™ aims to reduce the need for clinical studies in generic drug product approvals AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform. The platform was developed by Aptar's drug services company, Nanopharm. If validated, SmartTrack™ aims to reduce the need for clinical studies in generic drug product approvals by proving it can accurately predict clinical outcomes – removing a major barrier for pharma companies and regulators and paving the way for wider patient access to medications. This validation would estab

      4/16/25 8:00:00 AM ET
      $ATR
      Plastic Products
      Industrials

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on AptarGroup with a new price target

      Raymond James initiated coverage of AptarGroup with a rating of Outperform and set a new price target of $200.00

      1/7/25 9:09:40 AM ET
      $ATR
      Plastic Products
      Industrials
    • AptarGroup downgraded by BofA Securities with a new price target

      BofA Securities downgraded AptarGroup from Buy to Neutral and set a new price target of $173.00

      1/6/25 9:13:43 AM ET
      $ATR
      Plastic Products
      Industrials
    • AptarGroup upgraded by Jefferies with a new price target

      Jefferies upgraded AptarGroup from Hold to Buy and set a new price target of $215.00 from $155.00 previously

      10/14/24 7:25:09 AM ET
      $ATR
      Plastic Products
      Industrials

    $ATR
    Financials

    Live finance-specific insights

    See more
    • Aptar Reports First Quarter 2025 Results

      AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following first quarter results for the period ended March 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501642213/en/Aptar Reports First Quarter 2025 Results First Quarter 2025 Highlights (compared to the prior year quarter) Reported sales of $887 million, a 3% decrease, and reported net income of $79 million, a 5% decrease Core sales were flat and adjusted EBITDA increased 3% from the prior year to $183 mill

      5/1/25 5:03:00 PM ET
      $ATR
      Plastic Products
      Industrials
    • Aptar Declares Quarterly Dividend

      AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to stockholders of record as of May 1, 2025. As previously announced, Aptar will hold a conference call on Friday, May 2, 2025 at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the website. About Aptar

      4/17/25 5:00:00 PM ET
      $ATR
      Plastic Products
      Industrials
    • Aptar Reports Fourth Quarter and Annual 2024 Results

      AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter results due to solid operational performance driven by top and bottom line improvements. Results were driven by sales growth in pharma solutions, increased demand for closures technologies and productivity gains across the company. Reported sales increased by 1% and core sales increased by 2% due to a negative currency effect. Aptar reported net income of $101 million for the quarter, a 62% increase from the prior year. In addition, the quarterly results benefited from a lower effective tax rate. This press release features multimedi

      2/6/25 5:17:00 PM ET
      $ATR
      Plastic Products
      Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Segment President Tlili Hedi sold $563,642 worth of shares (3,614 units at $155.96), decreasing direct ownership by 28% to 9,379 units (SEC Form 4)

      4 - APTARGROUP, INC. (0000896622) (Issuer)

      5/19/25 10:11:13 AM ET
      $ATR
      Plastic Products
      Industrials
    • Director Glickman Sarah Js was granted 1,069 shares, increasing direct ownership by 53% to 3,076 units (SEC Form 4)

      4 - APTARGROUP, INC. (0000896622) (Issuer)

      5/9/25 9:28:24 AM ET
      $ATR
      Plastic Products
      Industrials
    • Chief Human Resources Officer Vinczeller Shiela sold $151,658 worth of shares (995 units at $152.42), decreasing direct ownership by 4% to 26,301 units (SEC Form 4)

      4 - APTARGROUP, INC. (0000896622) (Issuer)

      5/8/25 5:35:08 PM ET
      $ATR
      Plastic Products
      Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    See more
    • Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

      Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

      7/25/24 5:20:00 PM ET
      $ATR
      Plastic Products
      Industrials
    • Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

      AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

      9/5/23 5:00:00 PM ET
      $ATR
      Plastic Products
      Industrials
    • Aptar Appoints Julie Xing to its Board of Directors

      AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230220005172/en/Julie Xing Joins Aptar's Board of Directors (Photo: Aptar) With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie's leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. With her solid track record of business transformation in multiple g

      3/1/23 5:00:00 PM ET
      $ATR
      Plastic Products
      Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

      SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

      2/13/24 4:58:57 PM ET
      $ATR
      Plastic Products
      Industrials
    • SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

      SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

      2/12/24 3:08:10 PM ET
      $ATR
      Plastic Products
      Industrials
    • SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

      SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

      2/12/24 11:53:37 AM ET
      $ATR
      Plastic Products
      Industrials

    $ATR
    SEC Filings

    See more
    • SEC Form SD filed by AptarGroup Inc.

      SD - APTARGROUP, INC. (0000896622) (Filer)

      5/16/25 9:27:34 AM ET
      $ATR
      Plastic Products
      Industrials
    • SEC Form S-8 filed by AptarGroup Inc.

      S-8 - APTARGROUP, INC. (0000896622) (Filer)

      5/9/25 4:12:00 PM ET
      $ATR
      Plastic Products
      Industrials
    • AptarGroup Inc. filed SEC Form 8-K: Financial Statements and Exhibits

      8-K - APTARGROUP, INC. (0000896622) (Filer)

      5/8/25 9:02:00 AM ET
      $ATR
      Plastic Products
      Industrials